Perrigo (PRGO) Total Debt Growth (3y) (2016 - 2026)
Perrigo (PRGO) Total Debt Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 92.83% |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | -6.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -6.99% |
| Mar 28, 2026 | -3.97% |
| Dec 31, 2025 | -3.94% |
| Sep 27, 2025 | -3.93% |
| Jun 28, 2025 | -3.92% |
| Mar 29, 2025 | 1.05% |
| Dec 31, 2024 | 0.92% |
| Sep 28, 2024 | 10.22% |
| Jun 29, 2024 | 4.50% |
| Mar 30, 2024 | 4.51% |
| Dec 31, 2023 | 4.54% |
| Sep 30, 2023 | 4.70% |
| Jul 1, 2023 | -0.39% |
| Apr 1, 2023 | 5.73% |
| Dec 31, 2022 | 6.82% |
| Oct 1, 2022 | 6.91% |
| Jul 2, 2022 | 5.73% |
| Apr 2, 2022 | 2.99% |
| Dec 31, 2021 | 2.78% |
| Oct 2, 2021 | 2.83% |